Patients & Caregivers
We strive to be allies to our partners in the advocacy community and the patients, their families and caregivers.
We strive to be allies to our partners in the advocacy community and the patients, their families and caregivers.
At Taysha Gene Therapies, patients and families are at the center of our work.
Patients, caregivers and families of those affected by rare CNS diseases are the foundation for everything we do. We are committed to understanding the unique challenges faced by patients and caregivers and keeping their best interests at heart as we work to deliver impactful and potentially life-changing therapies.
Our decisions and activities are guided by the following principles:
Taysha is currently conducting research for an investigational gene therapy for Rett syndrome.
Information and support are available for families affected by Rett syndrome from advocacy organizations such as:
Families can also access resources on rare diseases, gene therapy, drug development and understanding clinical trials by visiting:
The Patients Affairs team at Taysha is dedicated to:
Emily McGinnis
Chief Patient and External Affairs Officer, and Endpoint and Outcome Development Lead
Chelsea Karbocus
Executive Director, Patient Advocacy
To connect with a member of our Patient Affairs team, please contact patientaffairs@tayshagtx.com.